Medicine and Dentistry
Analysis
16%
Antibody
50%
Antibody Conjugate
8%
Antibody Specificity
8%
Association
7%
Biodistribution
8%
Biological Marker
21%
Cancer Diagnosis
8%
Cancer Therapy
50%
Chemoradiation Therapy
10%
Chemotherapy
35%
Combination Therapy
8%
Conjugation
33%
Deep Vein Thrombosis
12%
Diagnostic Error
12%
Drug Dose Reduction
10%
Endoglin
50%
Gold Nanoparticle
50%
Hospital
7%
Immune Checkpoint Inhibitor
50%
Immunoglobulin
14%
In Vitro
8%
Inductively Coupled Plasma Mass Spectrometry
16%
Inflammation
50%
Injection
8%
Laboratory Assessment
12%
Lung
28%
Lung Cancer
7%
Lymphatic Drainage
10%
Lymphoscintigraphy
10%
Malignant Neoplasm
50%
Nanoparticle
8%
Neoplasm
50%
Non Small Cell Lung Cancer
50%
Nutritional Status
50%
Oncology
14%
Organ
8%
Overall Survival
7%
Patient
7%
Plasma
8%
Plummer-Vinson Syndrome
20%
Post-Analytical Phase
12%
Progression Free Survival
7%
Quality of Life Assessment
10%
Radioactive Tracer
16%
Retrospective Study
7%
Specific Tumor
8%
Therapeutic Procedure
14%
Zirconium 89
50%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody
64%
Antibody Conjugate
7%
Bevacizumab
7%
Biodistribution
7%
Chloramine-T
7%
Complication
50%
Endoglin
100%
Gold Nanoparticle
50%
Incidence
7%
Iodine 124
50%
Iodine-125
50%
Iodine-131
50%
Lutetium 177
50%
Malignant Neoplasm
50%
Monoclonal Antibody
7%
Monotherapy
7%
Mouse
7%
Nanoparticle
7%
Neoplasm
100%
Non Small Cell Lung Cancer
7%
Progression Free Survival
7%
Radioisotope
50%
Rhenium 188
50%
Side Effect
7%
Solid Malignant Neoplasm
50%
Toxicity
14%
Tracer
28%
Yttrium 90
50%
Zirconium 89
50%
Immunology and Microbiology
Angiogenesis
10%
Antibody Conjugate
8%
Antibody Specificity
8%
Bevacizumab
10%
Blood Plasma
8%
Cells
50%
Chloramine-T
10%
Conjugation
33%
Contrast
8%
Deiodination
50%
Endoglin
100%
Immunity
50%
Intravenous Immunoglobulin
9%
Isotope Labeling
10%
Lung
50%
Monospecific Antibody
50%
Mouse
8%
Organ
8%
Radioiodination
20%
Single Photon Emission Computed Tomography-Computed Tomography
50%
Systemic Inflammation
50%
Time
8%
